Trial Profile
A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary) ; Buprenorphine
- Indications Heroin-related disorders
- Focus Therapeutic Use
- Sponsors Integrated Therapeutics Group; Merck & Co; Merck Sharp & Dohme; Schering-Plough; Schering-Plough Research Institute
- 19 Jul 2019 This trial has been completed in France, according to European Clinical Trials Database
- 28 Jul 2014 New trial record
- 27 Jan 2010